apollo
0
Written By ,
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Last Updated Sep 30, 2024 | 4:52 PM IST

Jalra-Trio Tablet is an antidiabetic medicine used to treat Type II Diabetes. It contains Dapagliflozin (sodium-glucose cotransporter-2 inhibitors), Vildagliptin (dipeptidyl peptidase-4 inhibitor), and Metformin (biguanides), which work by increasing the amounts of certain natural substances that lower blood sugar when it is high. Jalra-Trio Tablet may cause side effects, such as vomiting, nausea, abdominal pain, headache, frequent urination, and allergic reactions.

Read more
61 people bought
in last 7 days
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

USV Pvt Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Apr-26

for this medicine

About Jalra-Trio Tablet

Jalra-Trio Tablet is an antidiabetic medicine used to treat diabetes. It is used for the treatment of Type II Diabetes. Type II Diabetes Mellitus is a chronic condition that influences the body's metabolism of glucose or blood sugar. Insulin resistance or insufficient insulin production are the two main causes of type 2 diabetes.

Jalra-Trio Tablet contains Dapagliflozin (sodium-glucose cotransporter-2 inhibitors), Vildagliptin (dipeptidyl peptidase-4 inhibitor), and Metformin (biguanides), which work by increasing the amounts of certain natural substances that lower blood sugar when it is high.

Jalra-Trio Tablet may cause certain side effects, such as vomiting, nausea, abdominal pain, headache, frequent urination, and allergic reactions. If these side effects persist or worsen, please consult your doctor. Jalra-Trio Tablet should be taken as prescribed by your doctor.

Jalra-Trio Tablet should be avoided if you are allergic to any of the medicines or their components. Inform your doctor about your medical history and the medicines you are taking, including herbs and supplements, before starting the treatment with Jalra-Trio Tablet . This can help prevent unwanted effects. Let your doctor know if you are pregnant or breastfeeding before taking Jalra-Trio Tablet . It is not recommended for use in children below 18 years of age.

Uses of Jalra-Trio Tablet

Treatment of Type II Diabetes Mellitus

Medicinal Benefits

Jalra-Trio Tablet  is a combination of three drugs, namely: Dapagliflozin, Vildagliptin, and Metformin. Jalra-Trio Tablet belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus. Vildagliptin enhances glucose-mediated insulin secretion, thereby reducing fasting and post-prandial blood sugar concentrations. Dapagliflozin helps remove excess sugar from the body via urine. Metformin helps reduce the sugar production by cells in the liver and delays sugar absorption from the intestines.

Directions for Use

Jalra-Trio Tablet should be taken as advised by your doctor. It is advised not to take more than the recommended dose. Swallow the medicine as a whole with a glass of water. Do not chew, crush, or break the medicine.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Jalra-Trio Tablet

  • Headache
  • Nausea
  • Stomach upset
  • Vomiting
  • Abdominal pain
  • Allergic reactions
  • Painful urination
  • Hypoglycaemia (low blood sugar)

Drug Warnings

Jalra-Trio Tablet should be avoided if you are allergic to any of the medicines or their components. Before starting the treatment, inform your doctor about your medical history and the medications you take, including herbs and supplements, to rule out any side effects. It is unknown whether Jalra-Trio Tablet can be given to pregnant women or breastfeeding mothers. Hence, inform your doctor if you are pregnant or breastfeeding. It is not recommended for use in children below 18 years of age. Avoid drinking alcohol while on Jalra-Trio Tablet  as it increases the risk of hypoglycemia and lactic acidosis (when the lactic acid increases in the body, which impacts the functioning of various organs in the body). Inform your doctor if you have any liver/kidney disease, heart problems, and hypertension before taking Jalra-Trio Tablet .

Drug Interactions

Drug-Drug Interactions: Jalra-Trio Tablet interacts with an anti-depressant (bupropion), drugs used to treat glaucoma, antibiotics (cephalexin, ciprofloxacin), anti-acidity drugs (cimetidine), heart condition drugs (digoxin), anti-epileptic drugs (topiramate, lamotrigine), heart-related chest medicine (ranolazine).

Drug-Food Interactions: Intake of excessive alcoholic beverages may increase the chance of a life-threatening condition known as Lactic acidosis. So, avoid intake of alcoholic beverages with Jalra-Trio Tablet .

Drug-Disease Interactions: Inform your doctor if you have any kidney or liver disease or heart problems.

Drug-Drug Interactions Checker List

  • RANOLAZINE
  • CIMETIDINE
  • DIGOXIN
  • BUPROPION
  • TOPIRAMATE

Habit Forming

No

Diet & Lifestyle Advise

  • Try doing 30 minutes of moderate-intensity physical activity or one hour and 15 minutes of high-intensity exercise weekly. 
  • Include your diet with whole grain foods, fruits and veggies and other fiber-enriched foods. 
  • Add omega-3 fatty acid-containing oils for daily cooking.
  • Avoid taking too much stress as it may elevate your blood sugar level. You can adopt stress management techniques like mindfulness to control stress-related blood sugar changes, meditation, or yoga.
  • Loss of weight gradually to achieve a healthy body mass index (18.5 to 24.9).
  • Keep your blood pressure as normal (140/90) as possible, as it reduces the risk of cardiovascular diseases in diabetes patients.
  • Avoid smoking and alcohol consumption while on treatment with Jalra-Trio Tablet .
  • Take short, frequent meals, and avoid prolonged fasting when taking Jalra-Trio Tablet .

Special Advise

  • Jalra-Trio Tablet may sometimes cause hypoglycemia (low blood sugar levels) as a side effect. Always carry a sugary food such as candy or fruit juice and consume them if you experience hypoglycaemia.
  • Lifestyle modifications are the most important step in controlling blood sugar levels.
  • Your doctor may advise frequent blood tests to check your blood sugar levels.

Disease/Condition Glossary

Type II Diabetes Mellitus: It is a chronic and lifelong condition wherein the body doesn’t use insulin effectively, which causes unusual blood glucose levels. Therefore, people affected with type 2 diabetes either do not produce enough insulin or there is resistance to the action of insulin. Individuals middle-aged or older are most likely to suffer from type 2 diabetes, which is also known as adult-onset diabetes. Symptoms of type 2 diabetes include increased thirst, frequent urination at night, slow wound healing, increased hunger, fatigue, weight gain, and blurred vision.

bannner image

Alcohol

Unsafe

Alcohol increases the impact of metformin on lactate metabolism. Hence, you should not consume excessive amounts of alcohol, either temporarily or permanently, while taking Jalra-Trio Tablet .

bannner image

Pregnancy

Consult your doctor

There are no adequate studies on the effect of Jalra-Trio Tablet in pregnancy. If you are pregnant or planning pregnancy, inform your doctor before taking Jalra-Trio Tablet .

bannner image

Breast Feeding

Caution

Jalra-Trio Tablet is generally not recommended in breastfeeding. Hence, if you are breastfeeding, inform your doctor before using Jalra-Trio Tablet .

bannner image

Driving

Safe

Jalra-Trio Tablet usually does not affect your ability to drive or operate machinery.

bannner image

Liver

Caution

Use Jalra-Trio Tablet with caution, as lactic acidosis can occur due to metformin accumulation. The risk increases with hepatic insufficiency. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Kidney

Caution

Renal impairment also increases the risk of lactic acidosis. Hence, Jalra-Trio Tablet should be used with caution if you have kidney problems. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

bannner image

Children

Unsafe

Jalra-Trio Tablet is not recommended for children below 18 years as the safety and effectiveness were not established.

Country of origin

India

Manufacturer/Marketer address

Arvind Vithal Gandhi Chowk, Bsd Marg, Station Road, Govandi East, Mumbai - 400 088. , India.
Other Info - JAL0051

FAQs

Jalra-Trio Tablet is an antidiabetic medicine used for the treatment of Type II Diabetes.
Jalra-Trio Tablet is a combination medicine containing Vildagliptin that enhances glucose-mediated insulin secretion, thereby reducing fasting and post-prandial blood sugar concentrations. Dapagliflozin helps remove excess sugar from the body via urine. Metformin helps reduce the sugar production by cells in the liver and delays sugar absorption from the intestines.
Please consult your doctor if you have concerns and for more information on this.
If you forget to take Jalra-Trio Tablet , take it as soon as you remember. However, if it's time for the next dose, avoid taking it and do not double dose to make up for the missed dose. Taking an overdose might cause your sugar level to fall down rapidly.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Recommended for a 30-day course: 3 Strips

Add 3 Strips